Search for: "Amneal Pharmaceuticals LLC" Results 1 - 20 of 42
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Oct 2019, 10:36 am by Renae Lloyd
As of last Tuesday, the biggest losers, included energy, healthcare and communications companies, according to Bloomberg: Amneal Pharmaceuticals LLC (AMRX CUSIP: 03168L105)  – $2.7 billion loan due 2025 has sunk to about 80 cents on the dollar, Seadrill Operating LP (SDRL CUSIP: G7998G106) – $2.6 billion loan maturing in 2021 fetches around 53 cents. [read post]
9 Oct 2018, 5:00 am by Anjelica Cappellino
Amneal Pharm., LLC, 2013 WL 1932927 at *9 (D.N.J. 2013) or it contains “substantial new data and information” exceeding the original report. [read post]
12 Sep 2018, 9:46 am by Eric Caligiuri
This case was originally filed in March 2016 by Galderma against Amneal Pharmaceuticals under the HatchWaxman Act, 35 U.S.C. [read post]
5 Sep 2018, 10:44 am by Jay W. Belle Isle
The ruling, following a four-day trial in Delaware federal court, is a victory for Robins Kaplan’s client, Amneal Pharmaceuticals LLC. [read post]
30 Apr 2018, 10:30 am by Doyle, Barlow & Mazard PLLC
On April 27, 2018, the FTC announced that Amneal Pharmaceuticals LLC (“Amneal”) may complete its acquisition of an equity share in Impax Laboratories Inc. [read post]
30 Apr 2018, 10:30 am by Doyle, Barlow & Mazard PLLC
On April 27, 2018, the FTC announced that Amneal Pharmaceuticals LLC (“Amneal”) may complete its acquisition of an equity share in Impax Laboratories Inc. [read post]
7 Dec 2017, 9:34 pm by Patent Docs
Seeking approval to market generic versions of Eli Lilly's Axiron® testosterone applicator, Defendants Perrigo Company and Perrigo Israel Pharmaceuticals Ltd., Actavis Laboratories UT, Inc., FKA Watson Laboratories Inc., Lupin Pharmaceuticals, Inc. and Lupin Ltd., and Amneal Pharmaceuticals LLC filed... [read post]
20 Apr 2017, 9:58 pm by Patent Docs
., Amneal Pharmaceuticals LLC, Amneal... [read post]
30 Jan 2017, 7:15 pm by FDABlog HPM
District Court for the District of Columbia, ANDA applicant Amneal Pharmaceuticals LLC (“Amneal”) alleges that FDA incorrectly ruled that Amneal forfeited eligibility for 180-day exclusivity for generic versions of NAMENDA XR (memantine HCl) Extended-release Capsules, 7 mg, 14 mg, 21 mg, and 28 mg. [read post]
8 Oct 2016, 3:25 am by Gregory B. Williams
Plaintiffs, Endo Pharmaceuticals Inc. and Mallinckrodt LLC, filed these patent infringement actions against defendants Amneal Pharmaceuticals, LLC, Amneal Pharmaceuticals of New York, LLC (collectively, “Amneal”), Teva Pharmaceuticals USA, Inc. and Barr Laboratories, Inc. [read post]
11 Apr 2016, 9:27 pm by Patent Docs
Amneal Pharmaceuticals, LLC 1:15-cv-00964; filed October 22, 2016 in the District Court of Delaware • Plaintiffs: Unimed Pharmaceuticals, LLC; Besins Healthcare Inc.; Besins Healthcare Luxembourg SARL • Defendant: Amneal Pharmaceuticals, LLC Infringement of U.S. [read post]
1 Feb 2016, 10:43 am by Lawrence B. Ebert
’” Greenliant Sys., Inc. v.Xicor LLC, 692 F.3d 1261, 1268 (Fed. [read post]
31 Jan 2016, 7:57 pm by Patent Docs
• Defendant: Amneal Pharmaceuticals LLC Infringement of U.S. [read post]